Latest News
Bitcoin is down 50% from its October 2025 peak. Here's what previous cycles say about the road ahead.
Via The Motley Fool · July 14, 2026
Long-term gold bulls need to be patient as there's probably still a lot of speculative money in the trade.
Via The Motley Fool · July 14, 2026
Kanovich liquidated his entire direct Class A position under a pre-arranged trading plan, though he retains 11.6 million convertible Class B shares.
Via The Motley Fool · July 14, 2026
The NioCorp CEO just gave investors great news.
Via The Motley Fool · July 14, 2026
Technology stocks are driving the broader market higher yet again in 2026.
Via The Motley Fool · July 14, 2026
Inflation slowed in June.
Via The Motley Fool · July 14, 2026
Amid satellite-disruption fears hitting telecoms, T-Mobile's spectrum swaps, SpaceX partnership, and enterprise push support analyst upgrades and a premium valuation versus AT&T and Verizon.
Via MarketBeat · July 14, 2026
Others are likely to perform better, but it may be a good addition to your portfolio.
Via The Motley Fool · July 14, 2026
TSMC's June revenue report suggests that the stock is poised for bigger gains in the second half of 2026.
Via The Motley Fool · July 14, 2026
The stock is poised to push beyond its $5.1 trillion market value.
Via The Motley Fool · July 14, 2026
The chipmaker got a vote of confidence from Wall Street.
Via The Motley Fool · July 14, 2026
The Goldman Sachs Group (NYSE:GS) reported record second-quarter 2026 results, with Chairman and Chief Executive Officer David Solomon citing strong client activity, an acceleration in strategic dealmaking and rising demand tied to artificial intelligence infrastructure investment.
Goldman generate
Via MarketBeat · July 14, 2026
FB Financial (NYSE:FBK) reported higher second-quarter 2026 earnings and balance sheet growth, with management pointing to broad-based loan demand across its Southeast footprint while acknowledging continued pressure from competition for deposits and lending relationships.
President and Chief Execu
Via MarketBeat · July 14, 2026
Selling a business is a little like selling a house. Even when the price is right, it’s easy to replay the "what ifs" long after the papers are signed. Billionaire entrepreneur and former Dallas Mavericks
Via Benzinga · July 14, 2026
AppLovin Corp (APP) stock bounces back after sell-off, supported at $442 level. Investor psychology creates & maintains support levels at $442 and $372.50.
Via Benzinga · July 14, 2026
Pourquoi choisir Trois-Rivières pour votre prochain logement ?Située entre Montréal et Québec, Trois-Rivières est une ville dynamique qui séduit autant les
Via Talk Markets · July 14, 2026
Johnson & Johnson stock trades near all-time highs. A strong Q2 report and the chart show more upside ahead.
Via Benzinga · July 14, 2026
Nebius shares gained after securing a multi-year AI infrastructure agreement worth over $1 billion with startup Reflection AI through 2029.
Via Benzinga · July 14, 2026
TSMC reported 67.9% June sales growth ahead of earnings, reinforcing billionaire Lewis Sanders' $9.5 billion investment in the AI chip giant.
Via Benzinga · July 14, 2026
Sandisk Corp. (NASDAQ:SNDK) stock surged 5% on Tuesday. Read how Goldman Sachs momentum data and Bank of America’s $2,500 price target drive the rebound.
Via Benzinga · July 14, 2026
ERShares' XOVR ETF makes Kalshi one of its largest private holdings after SpaceX, reinforcing its strategy of investing before companies go public.
Via Benzinga · July 14, 2026
Oracle shares slip as IBM's disappointing preliminary earnings pressure enterprise software stocks despite Oracle unveiling new AI capabilities.
Via Benzinga · July 14, 2026
The New Education Policy (NEP) 2020 is one of the most significant reforms in India's education system. Approved by the Government of India on 29 July 2020
Via Talk Markets · July 14, 2026
The opportunity behind these recently raised funds is nothing less than amazing.
Via The Motley Fool · July 14, 2026
Biogen stock drops 9% as Phase 2 diranersen data raises analyst questions, despite Phase 3 plans and a new weekly LEQEMBI FDA approval.
Via Benzinga · July 14, 2026